Colombo and Mundra ports

Navigating the Intelligent Tide: How AI and Generative AI are Reshaping Maritime Mobility in South Asia

The integration of AI and Generative AI is not a distant aspiration — it is an active investment already reshaping how ports operate, how cargo moves, and how supply chains absorb shocks. For India and its neighbours, the imperative is clear: build the data foundations, governance frameworks, and human capabilities that allow intelligent mobility to reach not just the terminal gate, but every link in the maritime supply chain.

The Splinternet and Fractured Digital World: Will Sovereignty Serve People, or the State, or Whoever Owns the Server?

Companies like Google, Meta, and X constantly shape public opinion and thoughts, and store public data for commercial usage. Amazon, Microsoft, and Google host the cloud infrastructure on which states and businesses depend. These are not ordinary companies anymore; they have access to critical intelligence and data. And now AI companies like Palantir use this data for surveillance, intelligence, monitoring, and on battlefields.

Non-Material ‘Presence’ in the Age of AI: A South Asian Reclamation of the Spirit Against the Machine

While TiME FLiES travels from 18th-century Boston to 20th-century Michigan and 21st-century Provence, its soul remains anchored in South Asian philosophy. It argues that while AI may simulate the "heart and mind," the true "presence" of consciousness—the Turiya—cannot be reduced to code.

Fighting Fire With Fire: How South Asia Can Use AI to Fight Cybercrime

The same generative AI that allows criminals to craft perfect phishing emails in Sinhala (or Hindi, Bangla and Urdu) or clone a Chief Financial Officer's voice from a YouTube clip, can also detect those emails before they reach an inbox and flag that voice as synthetic before a payment is authorised. The technology exists. The question is whether South Asia's institutions will deploy it in time.  

More on AI and Innovation

Hyderabad based Biological E. inks deal with Canadian company to manufacture mRNA vaccines

Hyderabad's Biological E. Limited has inked an agreement with Canada-based Providence Therapeutics to manufacture in its units mRNA coronavirus disease (Covid-19) vaccine, and run a pivotal trial in India for the jab

GoAir signs MoU with Jammu & Kashmir government for transportation of perishable fruits

The Jammu and Kashmir Horticulture Department has signed Memorandum of Understanding (MoU) with airline carrier GoAir for transportation of perishable horticulture and agricultural produce to various destinations across the country

India’s Adani Group to get 51 percent stake in planned new terminal of Sri Lanka’s Colombo port

India’s Adani Group will get a 51 percent stake in a planned west container terminal at Sri Lanka’s Colombo port under a 35-year build-operate-transfer concession, a media report said

Indian American tech company admits to H1-B visa fraud involving Indians

An Indian-American technology company has admitted to committing fraud to bring Indians on the coveted H1-B visas to the US, according to a federal prosecutor

IFFCO introduces the 'world’s first' Nano Urea

What is claimed to be the world’s first Nano Urea Liquid was introduced for Indian farmers by the Indian Farmers Fertiliser Cooperative Limited (IFFCO) Monday

Indian corporates low on optimism, ask for fresh fiscal package

There is a sharp deterioration in the optimism level of corporate India, with companies feeling the need for another fiscal package, on the back of a sweeping second wave of the Coronavirus infection, says the country’s leading trade body, Federation of Indian Chambers of Commerce & Industry (FICCI)

SII to supply 90 to 100 million Covishield doses in June

The Serum Institute of India (SII) has said it will be able to manufacture and supply 90 to 100 million doses of Covishield in June, reports said

Concerned about freedom of speech, intimidation in India: Twitter

After its offices were raided in India, global social networking giant Twitter has expressed its concerns about its "employees" in the country, "freedom of speech" and "intimidation tactics by the police"

India-Bangladesh joint venture to set up garment accessories and bag manufacturing unit

India-Bangladesh joint venture company Khyaati Leather Innovations BD Limited has signed an agreement with Bangladesh Export Processing Zones Authority (BEPZA) to establish a garments accessories and bags manufacturing unit in Ishwardi EPZ, at Pakshay in Pabna district of Bangladesh, with an investment of USD 2.95 million, reports BSS

UAE seeks investment from Indian pharma companies

The United Arab Emirates has sought Indian investment in the pharmaceutical sector and promised to support any such venture

Indian-origin perfume maker charters flight to save his Dubai business

A Dubai-based Indian origin businessman, who got stranded on a trip to his village in Assam state after UAE banned flights from Covid 19 battered India, spent Dh 277,000 (USD 75,415.91) to charter a flight for his eight-member family to Dubai to save his business, his son has revealed

WhatsApp files case in Delhi High Court against Indian government over digital rules

Messaging application WhatsApp has filed a lawsuit in the Delhi High Court against the Modi government's new digital rules effecting from Wednesday

Moderna's single-dose Covid19 vaccine may be in India by 2022

Moderna, the American pharma and biotech giant,  is planning to launch a single-dose vaccine for the Indian market only in 2022 as it has no surplus vaccines in 2021, media reports said

New IT rules: 'We aim to comply with the provisions of the IT rules', says Facebook hours before deadline

Hours before the expiry of the three-month deadline for compliance with itsIntermediary Guidelines, announced by the Indian government in February, global social media giant Facebook said it will comply with the new rules, media reports said

Regulatory approvals for India's Covaxin in process in more than 60 countries: Bharat Biotech

Amid travel fears that students receiving Covaxin may not be allowed in many countries as the vaccine is not listed, Hyderabad-based pharma major Bharat Biotech on Tuesday said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary